Plasma Fractionation Market worth US$ 52.64 billion by 2030 with a CAGR of 7.5%

 

The report "Global Plasma Fractionation Market, By Product Type (Albumin, Immunoglobulins, Coagulation factor concentrates, and Others), By Application (Neurology, Hematology, Immunology, Critical Care, and Others), By End User (Hospitals and Clinics, Clinical Research Laboratories, and Academic Institutes), and Region - Global Forecast to 2030" The Global Plasma Fractionation Market accounted for US$ 25.6 billion 2020 and is estimated to be US$ 52.64 billion by 2030 and is anticipated to register a CAGR of 7.5%. Rising incidence of immunologic disorders and growing use of immunoglobulin and alpha-1 antitrypsin are major factors driving growth of the global plasma fractionation market. In addition, increasing awareness of diseases such as hemophilia and rising incidence of sudden spreading of viral diseases across the globe are some among the major factors to raise the stakes for plasma fractionation by diagnostic centers. This factor leads to large-scale protein purification and ultimately propelling growth of the global plasma fractionation market. Innovation and development in cost effective plasmapheresis equipment’s by manufacturers and increasing number of hemophilic patients can create lucrative opportunity for players operating in the global plasma fractionation market.

Key Highlights:

  • In December 2017, BioLife Plasma Services L. P. had files for FDA approval of a new plasma manufacturing facility in Covington, Georgia to support growing immunology franchise.

Key Market Insights from the report:          

The Global Plasma Fractionation Market accounted for US$ 25.6 billion 2020 and is estimated to be US$ 52.64 billion by 2030 and is anticipated to register a CAGR of 7.5%. The market report has been segmented on the basis of product type, application, end user, and region.

  • By product type, the immunoglobulins segment is accounted for major revenue share in 2018, since it reduces adverse effects and drug reactions.

  • By application, the neurology segment is accounted for major revenue share in 2018, owing to rising incidences of neurological disorders and increasing aging population.

  • By end-user, the hospitals and clinics segment is accounted for major revenue share in 2018. This is due to improving infrastructure and healthcare facilities provided by hospitals, along with increasing off-label (non-approved) use of plasma fractionated products in hospitals for excessive bleeding due to trauma and surgery.

  • By region, North America plasma fractionation market accounted for major revenue share of the global plasma fractionation market and is further anticipated to maintain its dominance over the forecast period. Due to increasing use of immunoglobulins in neurological diseases, and availability of appropriate healthcare infrastructure in the countries of the North America region. Europe plasma fractionation market accounted for second-highest market share, in 2018. This is due to increasing use of plasma fractioned in neurological diseases, in treatment hemophilic patients, and increasing use of prophylaxis treatments for diagnosed patients in this region. Asia Pacific plasma fractionation market is expected to grow at the highest rate during the forecast period owing to high expenditure for development of proper healthcare infrastructure by governments of countries in the region.


Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/537

The prominent player operating in the global plasma fractionation market includes CSL Plasma, Inc., Grifols S.A., BioLife Plasma Services L. P., Octapharma Plasma, Inc., Kedrion S.p.A, Bio Product Laboratory Ltd., LFB S.A., Biotest Pharmaceuticals Corporation, Japan Blood Products Organization, and China Biologic Products Holdings, Inc.

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Membrane technology market accounted for US$ 25.0 billion in 2019 and is estimated to be US$ 48.7 billion by 2029 and is anticipated to register a CAGR of 7.0% .

Image
Membrane technology market accounted for US$ 25.0 billion in 2019 and is estimated to be US$ 48.7 billion by 2029 and is anticipated to register a CAGR of 7.0% The report " Global Membrane Technology Market, By Technology (Ultrafiltration, Chromatography, Microfiltration, Nanofiltration, Reverse Osmosis, and Electrodialysis) and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In July 2020, SUEZ announced that it has signed an agreement to purchase the Reverse Osmosis (RO) membrane portfolio from specialty chemical company LANXESS. The membrane will become part of the company’ Water Technologies & Solutions product portfolio and further enhances the business’ ability to help customers address water treatment challenges. In August 2020, Suez Water Technologies announced that the Region of Waterloo (Canada) has selected SUEZ’s ZeeLung technology to equip what will be the
Read more

Bioplastic Packaging Market is estimated to be US$ 77.1 billion by 2032 with a CAGR of 25.5% over the forecast period (2022-2032)

Image
Bioplastics are made by converting sugars in plants into plastic, in the United States, that sugar comes from corn, other countries use sugar cane, sugar beets, wheat, or potatoes, and this makes bioplastics renewable and better for the environment than conventional plastics. Unlike conventional plastics made from petroleum, bioplastics are made from renewable biomass sources such as vegetable fats and oils, corn starch, straw, woodchips, sawdust, recycled food waste, etc. Many types of bioplastics offer properties similar to conventional plastics such as durability, flexibility, etc. Food packaging should be natural and environmentally friendly, bioplastics or biopolymers from renewable resources have led to increasing industry interest in petroleum-based polymers as a solution to environmental problems and limited resources. Some bioplastics offer additional functionality, such as biodegradability or compostability, and improved properties, such as increased heat resistance, enhance
Read more

Citric Acid Market is estimated to be US$ 5.03 billion by 2030 with a CAGR of 4.50% during the forecast period.

Image
  Citric Acid Market accounted for US$ 3.26 billion in 2020 and is estimated to be US$ 5.03 billion by 2030 and is anticipated to register a CAGR of 4.50%. Citric acid, having the chemical formula C6H8O7, is a weak organic acid. Because of its features and characteristics, it is widely employed in a variety of end-use industries. It's generally utilised as a flavouring and chelating agent, as well as an acidifier. Citric acid, as one of the more potent edible acids, is commonly employed as a preservative in foods and beverages, particularly soft drinks. It's also used to clean limescale out of boilers and evaporators. The report   "   Global Citric Acid Market, By Form (Power and Liquid), By Application (Food & Beverages, Pharmaceuticals, Personal Care, and Others (detergents & cleansers, animal feed, textile)) and By Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa) - Trends, Analysis and Forecast till 2029’’ Key Highlights: In
Read more